RSSMicro.com Search - RSS Feed Search Engine - RSS Feed Directory
Dedicated RSS Feed Search Engine
 Search 3.2 million RSS feeds
The most comprehensive RSS feed search on the web
Top Stories  |  FeedRank Checker

Published

   Last Hour

   Last Day

   Past Week

   Past Month

 Anytime







Featured
RSS Feeds


CNN RSS Feeds

Reuters RSS Feeds

MSNBC RSS Feeds

New York Times RSS Feeds

Washington Post RSS Feeds

CNBC RSS Feeds

ABC News RSS Feeds

Fox News RSS Feeds

Sky News RSS Feeds

Forbes RSS Feeds

CNET RSS Feeds

Unicef RSS Feeds

PBS RSS Feeds

Wall Street Journal RSS Feeds

Financial Times RSS Feeds

Business Week RSS Feeds

Bloomberg RSS Feeds

TheStreet RSS Feeds

ESPN RSS Feeds

   


»Click here to calculate your site FeedRank Today«

FeedRank - RSSMicro Search

FeedRank, a newly developed algorithm for ranking RSS feeds only on RSSMicro
Click here to learn more




FeedRank: 4/10  4/10  Good  ---  www.injuryboard.com
This is an aggregated feed of all posts made to the InjuryBoard Blog Network. Currently there are over 100 geographically specific blogs covering topics that include auto accidents, harmful drugs, dangerous products, medical malpractice, head/brain injuries and much more. ...

 

 
Monday, April 28, 2008 --- 114 days ago
Late Friday the makers of Claritin and Singulair announced that the FDA has rejected an application for a pill combining the two drugs. Singulair , sold by Merck, is a popular medication used to treat asthma and combat allergies. Claritin , produced by Schering-Plough, offers a variety of OTC and prescription medications to treat the symptoms of allergies. The thought was that the combination of the two pills could provide a better solution for some patients by offering a congestion aid that is not demonstrated by the medications when administered separately. The FDA claims that several years of research failed to show an advantage when combining the two medications when treating seasonal allergies.   Combo pills just aren't causing a lot of happiness for Merck and Schering-Plough these days. The companies have been dealing with a firestorm over blockbuster combo pill Vytorin, which they market jointly. So we raised our eyebrow a bit upon reading a quote that Schering-Plough spokeswoman Lisa Ellen gave to Reuters after the Singulair-Claritin news came out: "We're still looking at it, and still evaluating the future of the joint venture as well." The comment inspired a headline on a post at the blog PharmaGossip that read, "Merck and Schering Plough - allergic to each other?"   Who know what the future is for combo pills, but for time being this might be the best thing ...




Recent Posts





 Facebook     Del.icio.us     Digg     StumbleUpon     Reddit     Google
Copyright © 2008 RSSMicro.com